Annual report pursuant to Section 13 and 15(d)

COMMITMENTS AND CONTINGENCIES (Details)

v3.24.0.1
COMMITMENTS AND CONTINGENCIES (Details)
$ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended 33 Months Ended
Jul. 31, 2023
USD ($)
Apr. 30, 2022
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Sep. 30, 2023
USD ($)
Dec. 31, 2021
Dec. 31, 2019
USD ($)
Product Liability Contingency [Line Items]                
Loan made prior to bankruptcy       $ 866 $ 10,104      
Liability recorded for building improvements     $ 2,000 $ 1,997 $ 0      
OGGUSA Debtors | Related Party                
Product Liability Contingency [Line Items]                
Approved preferential claim on bankruptcy $ 15,500              
Percentage reduction in general claim 0.50              
GenCanna Global Inc.                
Product Liability Contingency [Line Items]                
Related party receivable               $ 29,000
Non-Officer/Director Shareholder                
Product Liability Contingency [Line Items]                
Ownership interest (as a percent)     5.00%     5.00%    
Payments to shareholders           $ 300    
Payments to shareholders (per year)     $ 100          
MariMed Hemp Inc. | OGGUSA Debtors                
Product Liability Contingency [Line Items]                
Transfer of assets   $ 250            
Loan made prior to bankruptcy   600            
Damages sought   $ 200            
Ownership Interest | GenCanna Global Inc.                
Product Liability Contingency [Line Items]                
Percentage Owned               33.50%
Kind Therapeutics USA Inc.                
Product Liability Contingency [Line Items]                
Voting interest acquired             100.00%